161 related articles for article (PubMed ID: 7710909)
21. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of multidrug resistance to chemotherapy.
de Vries EG; Pinedo HM
Cancer Treat Res; 1991; 57():171-86. PubMed ID: 1686716
[No Abstract] [Full Text] [Related]
23. P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
Pallis M; Turzanski J; Higashi Y; Russell N
Leuk Lymphoma; 2002 Jun; 43(6):1221-8. PubMed ID: 12152989
[TBL] [Abstract][Full Text] [Related]
24. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
Massart C; Gibassier J; Raoul M; Pourquier P; Leclech G; Robert J; Lucas C
Anticancer Drugs; 1995 Feb; 6(1):135-46. PubMed ID: 7756676
[TBL] [Abstract][Full Text] [Related]
26. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
[TBL] [Abstract][Full Text] [Related]
27. A role for protein kinase C in the multidrug resistance phenotype of human carcinoma KB cell lines.
Drew L; Warr JR; Rumsby MG
Biochem Soc Trans; 1995 Aug; 23(3):447S. PubMed ID: 8566337
[No Abstract] [Full Text] [Related]
28. Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation.
Beltran PJ; Fan D; Fidler IJ; O'Brian CA
Biochem Pharmacol; 1997 Jan; 53(2):245-7. PubMed ID: 9037258
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of multiple drug resistance in human bladder cancer cell lines.
Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB
J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of multidrug resistance in breast cancer.
Glazer RI; Rohlff C
Breast Cancer Res Treat; 1994; 31(2-3):263-71. PubMed ID: 7881104
[TBL] [Abstract][Full Text] [Related]
31. KT-5720 reverses multidrug resistance in variant S49 mouse lymphoma cells transduced with the human MDR1 cDNA and in human multidrug-resistant carcinoma cells.
Galski H; Lazarovici P; Gottesman MM; Murakata C; Matsuda Y; Hochman J
Eur J Cancer; 1995; 31A(3):380-8. PubMed ID: 7786606
[TBL] [Abstract][Full Text] [Related]
32. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
33. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
34. Modulators of P-glycoprotein-associated multidrug resistance.
Beck WT
Cancer Treat Res; 1991; 57():151-70. PubMed ID: 1686715
[No Abstract] [Full Text] [Related]
35. Novel cellular determinants for reversal of multidrug resistance in cells expressing P170-glycoprotein.
Yin MB; Guo B; Voigt W; Vanhoefer U; Gibbs JF; Skenderis BS; Frank C; Wrzosek C; Rustum YM
Biochim Biophys Acta; 1998 Mar; 1401(3):265-76. PubMed ID: 9540817
[TBL] [Abstract][Full Text] [Related]
36. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
37. Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance.
Twentyman PR; Versantvoort CH
Eur J Cancer; 1996 Jun; 32A(6):1002-9. PubMed ID: 8763341
[No Abstract] [Full Text] [Related]
38. Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha.
Cloud-Heflin BA; McMasters RA; Osborn MT; Chambers TC
Eur J Biochem; 1996 Aug; 239(3):796-804. PubMed ID: 8774728
[TBL] [Abstract][Full Text] [Related]
39. Multidrug resistance reversal in childhood malignancies--potential for a real step forward?
Pinkerton CR
Eur J Cancer; 1996 Apr; 32A(4):641-4. PubMed ID: 8695268
[No Abstract] [Full Text] [Related]
40. Lung resistance-related protein: determining its role in multidrug resistance.
Dalton WS; Scheper RJ
J Natl Cancer Inst; 1999 Oct; 91(19):1604-5. PubMed ID: 10511581
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
